Substance Abuse Treatment Market Worth $20.51 Billion By 2030

Substance Abuse Treatment Market Growth & Trends

The global substance abuse treatment market size is expected to reach USD 20.51 billion by 2030, expanding at a CAGR of 9.05% from 2023 to 2030, according to a new report by Grand View Research, Inc. The growth is attributed to the increasing demand for therapeutic options as a result of the rising prevalence of substance abuse cases. For instance, according to the UNODCWorld Drug Report, in 2020, 284 million individuals aged between 15 and 64 years used drugs globally. Alcohol and tobacco are among the most extensively consumed psychoactive substances. They are also regarded as the most harmful psychoactive substances globally and are the leading causes of morbidity and mortality. The tobacco epidemic alone is one of the world’s most prominent public health concerns.

According to the WHO estimates, globally, there are 1.3 billion tobacco consumers, of which more than 8 million people die annually due to its consumption. Over 7 million tobacco deaths are the consequence of direct tobacco use, while about 1.2 million deaths are caused by passive smoking, where non-smokers are exposed to environmental tobacco smoke. Government initiatives to enable and advance healthcare settings to combat the rising concerns of substance abuse will drive market growth. For instance, in March 2020, researchers at Columbia University set up a new center due to the growing crisis associated with opioid and other substance use disorders. Various global initiatives spreading awareness about addiction treatment are among the major factors driving the industry growth.

For instance, the WHO celebrates World No Tobacco Day on May 31st each year. In addition, in June 2021, DC Health launched the public education campaign, MyRecoveryDC, to help provide access to treatments and recovery services for substance abuse. In October 2022, Qnovia raised USD 17 million to fight against nicotine addiction. Furthermore, key players are focusing on collaborations and partnerships to develop novel therapeutics for drug addiction treatment and maintain their competitive position in the market. For instance, in November 2022, Opiant Pharmaceuticals, Inc. entered into a definitive agreement with Indivior PLC to strengthen its position as the leader in addiction treatment. The acquisition is expected to give rights of Opiant’s pipeline product, OPNT003, an opioid overdose treatment, after its approval and launch.

Players are entering the drug addiction treatment market attributable to enhanced revenue generation possibilities in the treatment of drug addiction. For instance, in January 2023, Hikma announced the launch of its prefilled Naloxone Hydrochloride Injection, for the treatment of opioid overdose in the U.S. The growing need for effective drug addiction treatment in the U.S. and enhanced government support is expected to boost demand for drug addiction treatment.

 Request a free sample copy or view the report summary: Substance Abuse Treatment Market Report

Substance Abuse Treatment Market Report Highlights

• The tobacco/nicotine & vaping segment dominated the industry in 2022 due to the high public awareness regarding the adverse effects associated with its consumption

• The alcohol segment is expected to register the fastest growth rate over the forecast period owing to the high consumption rate associated with alcohol

• The hospitals segment dominated the industry in 2022 due to the ease of availability of various drug addiction treatments in hospital settings

• North America was the dominant regional market in 2022 due to the increased substance abuse cases along with high investments to provide effective treatments

Substance Abuse Treatment Market Segmentation

Grand View Research has segmented the global substance abuse treatment market based on treatment type, end-use, and region:

Substance Abuse Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)

• Tobacco/Nicotine & Vaping

• Alcohol

• Marijuana

• Synthetic Cannabinoids

• Prescription & Over-the-counter Medications

• Others

Substance Abuse Treatment End-Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Clinics

• Rehabilitation Centers

• Others

Substance Abuse Treatment Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • U.K.

  • Germany

  • Spain

  • France

  • Italy

  • Denmark

  • Norway

  • Sweden

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Substance Abuse Treatment Market

• Teva Pharmaceutical Industries Ltd.

• Abbott

• GSK plc.

• Cipla Inc.

• Lilly (Eli Lilly and Company)

• Novartis AG

• Sun Pharmaceutical Industries Ltd.

• Dr. Reddy’s Laboratories Ltd.

• Viatris Inc.

• AstraZeneca